- Home
- SLDB vs TALK Comparison
SLDB vs TALK Comparison
Compare SLDB & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLDB
- TALK
- Stock Information
- Founded
- SLDB 2013
- TALK 2012
- Country
- SLDB United States
- TALK United States
- Employees
- SLDB N/A
- TALK N/A
- Industry
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- TALK Medical/Nursing Services
- Sector
- SLDB Health Care
- TALK Health Care
- Exchange
- SLDB Nasdaq
- TALK Nasdaq
- Market Cap
- SLDB 433.0M
- TALK 437.1M
- IPO Year
- SLDB 2018
- TALK N/A
- Fundamental
- Price
- SLDB $5.44
- TALK $2.65
- Analyst Decision
- SLDB Strong Buy
- TALK Buy
- Analyst Count
- SLDB 10
- TALK 6
- Target Price
- SLDB $15.00
- TALK $4.50
- AVG Volume (30 Days)
- SLDB 771.9K
- TALK 1.0M
- Earning Date
- SLDB 11-05-2025
- TALK 10-28-2025
- Dividend Yield
- SLDB N/A
- TALK N/A
- EPS Growth
- SLDB N/A
- TALK N/A
- EPS
- SLDB N/A
- TALK 0.02
- Revenue
- SLDB N/A
- TALK $202,611,000.00
- Revenue This Year
- SLDB N/A
- TALK $22.35
- Revenue Next Year
- SLDB N/A
- TALK $21.66
- P/E Ratio
- SLDB N/A
- TALK $153.76
- Revenue Growth
- SLDB N/A
- TALK 17.43
- 52 Week Low
- SLDB $2.41
- TALK $1.88
- 52 Week High
- SLDB $8.10
- TALK $4.36
- Technical
- Relative Strength Index (RSI)
- SLDB 45.94
- TALK 54.16
- Support Level
- SLDB $4.87
- TALK $2.49
- Resistance Level
- SLDB $5.79
- TALK $2.64
- Average True Range (ATR)
- SLDB 0.32
- TALK 0.09
- MACD
- SLDB 0.02
- TALK -0.01
- Stochastic Oscillator
- SLDB 62.50
- TALK 71.11
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.